| Envelope residue 375 substitutions in simian–human immunodeficiency viruses enhance CD4 binding and replication in rhesus macaques H Li, S Wang, R Kong, W Ding, FH Lee, Z Parker, E Kim, GH Learn, ... Proceedings of the National Academy of Sciences 113 (24), E3413-E3422, 2016 | 209 | 2016 |
| Multiple vaccine-elicited nonneutralizing antienvelope antibody activities contribute to protective efficacy by reducing both acute and chronic viremia following simian/human … P Xiao, J Zhao, LJ Patterson, E Brocca-Cofano, D Venzon, PA Kozlowski, ... Journal of virology 84 (14), 7161-7173, 2010 | 192 | 2010 |
| Inflammatory monocytes expressing tissue factor drive SIV and HIV coagulopathy ME Schechter, BB Andrade, T He, GH Richter, KW Tosh, BB Policicchio, ... Science translational medicine 9 (405), eaam5441, 2017 | 118 | 2017 |
| Replicating adenovirus-simian immunodeficiency virus (SIV) recombinant priming and envelope protein boosting elicits localized, mucosal IgA immunity in rhesus macaques … P Xiao, LJ Patterson, S Kuate, E Brocca-Cofano, MA Thomas, D Venzon, ... Journal of virology 86 (8), 4644-4657, 2012 | 101 | 2012 |
| Targeting the vaginal mucosa with human papillomavirus pseudovirion vaccines delivering simian immunodeficiency virus DNA SN Gordon, RC Kines, G Kutsyna, ZM Ma, A Hryniewicz, JN Roberts, ... The Journal of Immunology 188 (2), 714-723, 2012 | 90 | 2012 |
| The Tat protein broadens T cell responses directed to the HIV-1 antigens Gag and Env: implications for the design of new vaccination strategies against AIDS R Gavioli, S Cellini, A Castaldello, R Voltan, E Gallerani, F Gagliardoni, ... Vaccine 26 (5), 727-737, 2008 | 76 | 2008 |
| DNA prime and protein boost immunization with innovative polymeric cationic core-shell nanoparticles elicits broad immune responses and strongly enhance cellular responses of … A Castaldello, E Brocca-Cofano, R Voltan, C Triulzi, G Altavilla, M Laus, ... Vaccine 24 (29-30), 5655-5669, 2006 | 71 | 2006 |
| Systemic neutralizing antibodies induced by long interval mucosally primed systemically boosted immunization correlate with protection from mucosal SHIV challenge WMJM Bogers, D Davis, I Baak, E Kan, S Hofman, Y Sun, D Mortier, ... Virology 382 (2), 217-225, 2008 | 68 | 2008 |
| Dynamics of memory B-cell populations in blood, lymph nodes, and bone marrow during antiretroviral therapy and envelope boosting in simian immunodeficiency virus SIVmac251 … T Demberg, E Brocca-Cofano, P Xiao, D Venzon, D Vargas-Inchaustegui, ... Journal of virology 86 (23), 12591-12604, 2012 | 60 | 2012 |
| Preparation and characterization of innovative protein-coated poly (methylmethacrylate) core-shell nanoparticles for vaccine purposes R Voltan, A Castaldello, E Brocca-Cofano, G Altavilla, A Caputo, M Laus, ... Pharmaceutical Research 24, 1870-1882, 2007 | 60 | 2007 |
| Neutrophil extracellular trap production contributes to pathogenesis in SIV-infected nonhuman primates R Sivanandham, E Brocca-Cofano, N Krampe, E Falwell, ... The Journal of clinical investigation 128 (11), 5178-5183, 2018 | 59 | 2018 |
| Inhibition of Human Immunodeficiency Virus Type 1 Tat-trans-Activation-Responsive Region Interaction by an Antiviral Quinolone Derivative S Richter, C Parolin, B Gatto, C Del Vecchio, E Brocca-Cofano, A Fravolini, ... Antimicrobial agents and chemotherapy 48 (5), 1895-1899, 2004 | 59 | 2004 |
| Vaccine-elicited SIV and HIV envelope-specific IgA and IgG memory B cells in rhesus macaque peripheral blood correlate with functional antibody responses and reduced viremia E Brocca-Cofano, K McKinnon, T Demberg, D Venzon, R Hidajat, P Xiao, ... Vaccine 29 (17), 3310-3319, 2011 | 58 | 2011 |
| Induction of humoral and enhanced cellular immune responses by novel core–shell nanosphere-and microsphere-based vaccine formulations following systemic and mucosal administration A Caputo, A Castaldello, E Brocca-Cofano, R Voltan, F Bortolazzi, ... Vaccine 27 (27), 3605-3615, 2009 | 57 | 2009 |
| Red blood cell-mediated delivery of recombinant HIV-1 Tat protein in mice induces anti-Tat neutralizing antibodies and CTL S Dominici, ME Laguardia, G Serafini, L Chiarantini, C Fortini, ... Vaccine 21 (17-18), 2073-2081, 2003 | 48 | 2003 |
| Novel biocompatible anionic polymeric microspheres for the delivery of the HIV-1 Tat protein for vaccine application A Caputo, E Brocca-Cofano, A Castaldello, R De Michele, G Altavilla, ... Vaccine 22 (21-22), 2910-2924, 2004 | 46 | 2004 |
| Transcription pattern of human herpesvirus 8 open reading frame K3 in primary effusion lymphoma and Kaposi's sarcoma P Rimessi, A Bonaccorsi, M Stürzl, M Fabris, E Brocca-Cofano, ... Journal of virology 75 (15), 7161-7174, 2001 | 45 | 2001 |
| Increased excitability in tat-transgenic mice: role of tat in HIV-related neurological disorders S Zucchini, A Pittaluga, E Brocca-Cofano, M Summa, M Fabris, ... Neurobiology of disease 55, 110-119, 2013 | 42 | 2013 |
| Antibody to the gp120 V1/V2 loops and CD4+ and CD8+ T cell responses in protection from SIVmac251 vaginal acquisition and persistent viremia SN Gordon, MN Doster, RC Kines, BF Keele, E Brocca-Cofano, Y Guan, ... The Journal of Immunology 193 (12), 6172-6183, 2014 | 34 | 2014 |
| The increase in intra-macrophage thiols induced by new pro-GSH molecules directs the Th1 skewing in ovalbumin immunized mice A Fraternale, MF Paoletti, S Dominici, A Caputo, A Castaldello, E Millo, ... Vaccine 28 (48), 7676-7682, 2010 | 34 | 2010 |
